RATIONALE: Although lipids, apolipoproteins, and lipoprotein particles are important modulators of inflammation, varying relationships exist between these parameters and asthma. OBJECTIVES: To determine whether serum lipids and apolipoproteins correlate with the severity of airflow obstruction in subjects with atopy and asthma. METHODS: Serum samples were obtained from 154 atopic and nonatopic subjects without asthma, and 159 subjects with atopy and asthma. Serum lipid and lipoprotein levels were quantified using standard diagnostic assays and nuclear magnetic resonance (NMR) spectroscopy. Airflow obstruction was assessed by FEV1% predicted. MEASUREMENTS AND MAIN RESULTS: Serum lipid levels correlated with FEV1 only in the subjects with atopy and asthma. Serum levels of high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I (apoA-I) were positively correlated with FEV1 in subjects with atopy and asthma, whereas a negative correlation existed between FEV1 and serum levels of triglycerides, low-density lipoprotein (LDL) cholesterol, apolipoprotein B (apoB), and the apoB/apoA-I ratio. NMR spectroscopy identified a positive correlation between FEV1 and HDLNMR particle size, as well as the concentrations of large HDLNMR particles and total IDLNMR (intermediate-density lipoprotein) particles in subjects with atopy and asthma. In contrast, LDLNMR particle size and concentrations of LDLNMR and VLDLNMR (very-low-density lipoprotein) particles were negatively correlated with FEV1 in subjects with atopy and asthma. CONCLUSIONS: In subjects with atopy and asthma, serum levels of apoA-I and large HDLNMR particles are positively correlated with FEV1, whereas serum triglycerides, LDL cholesterol, and apoB are associated with more severe airflow obstruction. These results may facilitate future studies to assess whether apoA-I and large HDLNMR particles can reduce airflow obstruction and disease severity in asthma.
RATIONALE: Although lipids, apolipoproteins, and lipoprotein particles are important modulators of inflammation, varying relationships exist between these parameters and asthma. OBJECTIVES: To determine whether serum lipids and apolipoproteins correlate with the severity of airflow obstruction in subjects with atopy and asthma. METHODS: Serum samples were obtained from 154 atopic and nonatopic subjects without asthma, and 159 subjects with atopy and asthma. Serum lipid and lipoprotein levels were quantified using standard diagnostic assays and nuclear magnetic resonance (NMR) spectroscopy. Airflow obstruction was assessed by FEV1% predicted. MEASUREMENTS AND MAIN RESULTS: Serum lipid levels correlated with FEV1 only in the subjects with atopy and asthma. Serum levels of high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I (apoA-I) were positively correlated with FEV1 in subjects with atopy and asthma, whereas a negative correlation existed between FEV1 and serum levels of triglycerides, low-density lipoprotein (LDL) cholesterol, apolipoprotein B (apoB), and the apoB/apoA-I ratio. NMR spectroscopy identified a positive correlation between FEV1 and HDLNMR particle size, as well as the concentrations of large HDLNMR particles and total IDLNMR (intermediate-density lipoprotein) particles in subjects with atopy and asthma. In contrast, LDLNMR particle size and concentrations of LDLNMR and VLDLNMR (very-low-density lipoprotein) particles were negatively correlated with FEV1 in subjects with atopy and asthma. CONCLUSIONS: In subjects with atopy and asthma, serum levels of apoA-I and large HDLNMR particles are positively correlated with FEV1, whereas serum triglycerides, LDL cholesterol, and apoB are associated with more severe airflow obstruction. These results may facilitate future studies to assess whether apoA-I and large HDLNMR particles can reduce airflow obstruction and disease severity in asthma.
Authors: Robert S Rosenson; H Bryan Brewer; W Sean Davidson; Zahi A Fayad; Valentin Fuster; James Goldstein; Marc Hellerstein; Xian-Cheng Jiang; Michael C Phillips; Daniel J Rader; Alan T Remaley; George H Rothblat; Alan R Tall; Laurent Yvan-Charvet Journal: Circulation Date: 2012-04-17 Impact factor: 29.690
Authors: S-W Park; E H Lee; E-J Lee; H J Kim; D-J Bae; S Han; D Kim; A S Jang; S-T Uh; Y H Kim; D J Erle; C-S Park Journal: Clin Exp Allergy Date: 2013-08 Impact factor: 5.018
Authors: F Erel; M Gulec; O Kartal; Z Caliskaner; S Ozturk; H Yaman; Y Kurt; E Gocgeldic; F Ors; M Karaayvaz Journal: Allergol Immunopathol (Madr) Date: 2007 Nov-Dec Impact factor: 1.667
Authors: Kian Fan Chung; Sally E Wenzel; Jan L Brozek; Andrew Bush; Mario Castro; Peter J Sterk; Ian M Adcock; Eric D Bateman; Elisabeth H Bel; Eugene R Bleecker; Louis-Philippe Boulet; Christopher Brightling; Pascal Chanez; Sven-Erik Dahlen; Ratko Djukanovic; Urs Frey; Mina Gaga; Peter Gibson; Qutayba Hamid; Nizar N Jajour; Thais Mauad; Ronald L Sorkness; W Gerald Teague Journal: Eur Respir J Date: 2013-12-12 Impact factor: 16.671
Authors: Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley Journal: Nat Cell Biol Date: 2011-03-20 Impact factor: 28.824
Authors: Ying Huang; Joseph A DiDonato; Bruce S Levison; Dave Schmitt; Lin Li; Yuping Wu; Jennifer Buffa; Timothy Kim; Gary S Gerstenecker; Xiaodong Gu; Chandra S Kadiyala; Zeneng Wang; Miranda K Culley; Jennie E Hazen; Anthony J Didonato; Xiaoming Fu; Stela Z Berisha; Daoquan Peng; Truc T Nguyen; Shaohong Liang; Chia-Chi Chuang; Leslie Cho; Edward F Plow; Paul L Fox; Valentin Gogonea; W H Wilson Tang; John S Parks; Edward A Fisher; Jonathan D Smith; Stanley L Hazen Journal: Nat Med Date: 2014-01-26 Impact factor: 53.440
Authors: Deepa Rastogi; Molly Jung; Garrett Strizich; Pamela A Shaw; Sonia M Davis; Oana L Klein; Frank J Penedo; Andrew L Ries; Martha L Daviglus; Juan J Moreiras; Matthias A Salathe; Juan C Celedón; Carmen R Isasi; Robert C Kaplan Journal: Respir Med Date: 2017-03-06 Impact factor: 3.415
Authors: Anna J Podolanczuk; Ganesh Raghu; Michael Y Tsai; Steven M Kawut; Eric Peterson; Rajiv Sonti; Daniel Rabinowitz; Craig Johnson; R Graham Barr; Karen Hinckley Stukovsky; Eric A Hoffman; J Jeffrey Carr; Firas S Ahmed; David R Jacobs; Karol Watson; Steven J Shea; David J Lederer Journal: Thorax Date: 2017-01-27 Impact factor: 9.139
Authors: Amisha V Barochia; Elizabeth M Gordon; Maryann Kaler; Rosemarie A Cuento; Patricia Theard; Debbie M Figueroa; Xianglan Yao; Nargues A Weir; Maureen L Sampson; Mario Stylianou; David F Choy; Cecile T J Holweg; Alan T Remaley; Stewart J Levine Journal: J Lipid Res Date: 2017-06-27 Impact factor: 5.922
Authors: Or Kalchiem-Dekel; Xianglan Yao; Amisha V Barochia; Maryann Kaler; Debbie M Figueroa; William B Karkowsky; Elizabeth M Gordon; Meixia Gao; Maria M Fergusson; Xuan Qu; Poching Liu; Yuesheng Li; Fayaz Seifuddin; Mehdi Pirooznia; Stewart J Levine Journal: Am J Respir Cell Mol Biol Date: 2020-08 Impact factor: 6.914
Authors: Benjamin T Suratt; Niki D J Ubags; Deepa Rastogi; Kelan G Tantisira; Benjamin J Marsland; Irina Petrache; Janice B Allen; Jason H T Bates; Fernando Holguin; Meredith C McCormack; Evangelos D Michelakis; Stephen M Black; Manu Jain; Ana L Mora; Viswanathan Natarajan; Yury I Miller; Michael B Fessler; Konstantin G Birukov; Ross S Summer; Stephanie A Shore; Anne E Dixon Journal: Ann Am Thorac Soc Date: 2017-06